Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
CrowdStrike Firm Which Peddled 'Russian Hacking' Conspiracy Theory Retracts Claims
Michael Moore Says Trump Will Cause Human Extinction
Mass. State Rep Michelle DuBois Tips Off Illegals to ICE Raids
MSNBC Panelist: I Get To Decide "What Racism Is" And You Don't
CNN's Stelter Attacks Fox News For Covering Story Of Illegal Immigrants Raping Girl At School
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.